D. S. Sander

DiarrheagenicEscherichia coli

Serum IgG mediates mucosal immunity against rotavirus infection

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy

Rotavirus Vaccines: Development, Current Issues and Future Prospects

Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis.

Review on heterogeneous photocatalytic disinfection of waterborne, airborne, and foodborne viruses: Can we win against pathogenic viruses?

Human Milk Composition

The Infectivity ofCryptosporidium parvumin Healthy Volunteers

Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq®

What Makes Clinical Research Ethical?

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries1Prepared as a review for the Consensus Workshop on Rotavirus Vaccines for use in Developing Countries, Geneva, January 9–10, 1997. Sponsored by: The Global Programme for Vaccines, World Health Organization, The Children's Vaccine Initiative and the Centers for Disease Control and Prevention.1

Immunity and correlates of protection for rotavirus vaccines

A Controlled Trial of Bismuth Subsalicylate in Infants with Acute Watery Diarrheal Disease

Rotavirus

The Role of Serum Antibodies in the Protection against Rotavirus Disease: An Overview

Enteric viruses in the aquatic environment

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

Viral pathogens in water: occurrence, public health impact, and available control strategies

Microbiota Modulation of the Gut-Lung Axis in COVID-19

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

Intussusception among Infants Given an Oral Rotavirus Vaccine

Rotavirus Infection in Infants as Protection against Subsequent Infections

How many child deaths can we prevent this year?

Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: A review

The actions of bismuth in the treatment of Helicobacter pylori infection

Rotavirus vaccines: viral shedding and risk of transmission

Rotavirus infection

Anti-Rotavirus G Type-Specific and Isotype-Specific Antibodies in Children with Natural Rotavirus Infections

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

SARS-CoV-2 in wastewater: State of the knowledge and research needs

Surveillance for rotavirus in Argentina

Modeling the Risk From Giardia and Viruses in Drinking Water

Rotavirus and Severe Childhood Diarrhea

Pharmaceuticals and the Developing World

Pathogenesis ofHelicobacter pyloriInfection

Causes of neonatal and child mortality in India: a nationally representative mortality survey

Heterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles

Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease

Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection

Global Illness and Deaths Caused by Rotavirus Disease in Children

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients

Correlates of Protection Induced by Vaccination

Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/Bovine Reassortant Rotavirus Vaccine

Protection from Rotavirus Reinfection: 2-Year Prospective Study

Reductions in Cross‐Neutralizing Antibody Responses in Infants after Attenuation of the Human Rotavirus Vaccine Candidate 89‐12

Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine

Evaluation of WC3 Rotavirus Vaccine and Correlates of Protection in Healthy Infants

Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children

In vitro activities of bismuth salts against rotaviruses and other enteric viruses

Studies of Echovirus-12 in Volunteers: Determination of Minimal Infectious Dose and the Effect of Previous Infection on Infectious Dose